The establishment of diagnosis and treatment subjects and systematic construction of the department of transfusion medicine in China: current status, challenges, and prospects
10.13303/j.cjbt.issn.1004-549x.2026.05.001
- VernacularTitle:我国输血医学科诊疗科目设置与体系化建设：现状、挑战与展望
- Author:
Yang YU
1
;
Rong XIA
2
Author Information
1. Department of Transfusion Medicine, The First Medical Center of the PLA General Hospital, Beijing 100853, China
2. Department of Transfusion, Affiliated Huashan Hospital of Fudan University, Shanghai 200040, China
- Publication Type:Journal Article
- Keywords:
department of transfusion medicine;
diagnosis and treatment subjects;
discipline development;
clinical practice licensing;
professional title promotion;
patient blood management;
hemovigilance
- From:
Chinese Journal of Blood Transfusion
2026;39(5):571-579
- CountryChina
- Language:Chinese
-
Abstract:
As a vital component of clinical medicine, transfusion medicine was officially recognized as a secondary clinical discipline (code 320.32) in 2016 through Amendment No. 2 to the national standard GB/T 13745-2009 Classification and Code of Disciplines. However, the current Catalogue of Diagnosis and Treatment Subjects for Medical Institutions has not yet established "Transfusion Medicine" as a formal subject. This omission has left transfusion departments in medical institutions across the country without a legitimate basis for clinical practice, creating an institutional dilemma in which departments bear statutory responsibilities and operate as substantive clinical units yet lack a corresponding diagnosis and treatment subject. This predicament severely constrains legal compliance in clinical practice, the development of the disciplinary workforce, education and training, research and innovation, and the enhancement of clinical service capacity. This article systematically reviews the necessity, policy basis, and disciplinary framework for establishing transfusion medicine as a formal diagnosis and treatment subject, aiming to provide evidence-based references for the National Health Commission to revise the Catalogue of Diagnosis and Treatment Subjects for Medical Institutions, and to promote the comprehensive transformation of China's transfusion medicine from a "blood storage and distribution" model toward a "clinically engaged, therapy-oriented" paradigm.
